United States · FDA National Drug Code directory

DAPAGLIFLOZIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50090-7057_593bc861-fc6b-408d-8a45-b08745301f02
Product NDC
50090-7057
Form
TABLET, FILM COATED
Composition / generic term
DAPAGLIFLOZIN
Labeler
A-S Medication Solutions
Marketing category
NDA AUTHORIZED GENERIC
Marketing start / end (source format)
20240103
Source listing expiry
20261231

Source-listed ingredients

  • DAPAGLIFLOZIN PROPANEDIOL — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-7057-0) · 50090-7057-0

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →